India vs Oman: Share of e coli bloodstream infections due to antimicrobial resistant
India
77.53
in 2022
Oman
78.16
in 2022
India rank
4th
Oman rank
3rd
Share of e coli bloodstream infections due to antimicrobial resistant over time
- India
- Oman
How they compare
Oman currently reports 78.16 against 77.53 in India, a difference of 0.63.
The two have swapped places 1 time across 6 shared years of data; in 2017 it was India ahead.
India ranks 4th and Oman ranks 3rd of 46 countries.
India has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | India | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 78.25 | 52.15 | 26.1 | India |
| 2020s | 80.64 | 73.66 | 6.98 | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e coli bloodstream infections due to antimicrobial resistant, India or Oman?
- Oman, at 78.16 against 77.53 in India as of 2022.
- What is the difference in share of e coli bloodstream infections due to antimicrobial resistant between India and Oman?
- 0.63, with Oman ahead.
- How many years of comparable data are there for India and Oman?
- 6 years are reported by both, from 2017 to 2022.
- How do India and Oman rank globally for share of e coli bloodstream infections due to antimicrobial resistant?
- India ranks 4th and Oman ranks 3rd of 46 countries.
- Where does this data come from?
- Our World in Data, published as Share of e coli bloodstream infections due to antimicrobial resistant bacteria. Statizoid refreshes it automatically from the source and publishes the full history for both places.